• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Pregnancy and Postpartum Course
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Topics » Addiction Treatment

Addiction Treatment
Addiction Treatment RSS Feed RSS

Clinical Update

Gabapentin: A Double-Edged Sword

April 1, 2023
Noah Capurso, MD and Shram Shukla, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Shram Shukla, MD. Addiction psychiatry fellow, Yale School of Medicine. New Haven, CT.

Noah Capurso, MD, MHS. Assistant professor of psychiatry, Yale University. New Haven, CT. Editor-in-chief of The Carlat Addiction Treatment Report.

Dr. Shukla and Dr. Capurso have no financial relationships with companies related to this material.

Gabapentin has become one of the most widely prescribed medications in America. At the same time, concerns have emerged about its association with opioid overdose deaths. In this article, we review the data behind gabapentin treatment: when it should be used, how to use it, and when it should be avoided.


Read More
Expert Q&A

Substance-Induced Depression: Diagnosis and Treatment

April 1, 2023
Bryan K. Tolliver, MD, PhD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

CATR_QA2_Headshot_Tolli.jpgBryan K. Tolliver, MD, PhD

Associate professor, Addiction Sciences Division, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina. Charleston, SC.

Dr. Tolliver has no financial relationships with companies related to this material.

“When tailoring medication choice, a careful history can guide you. If I’m treating a patient who drinks excessively at night to sleep or who struggles with insomnia when they try to stop drinking, I’ll start with a sedating antidepressant like mirtazapine. That’s not an evidence-based decision, it’s a clinical decision that I think can be helpful.”

Dr. Tolliver gives us a framework to understand the relation between depression, substance use, and substance-induced mood disorders.


Read More
psychosis.jpeg
Expert Q&A

Recognizing and Treating Substance-Induced Psychosis

April 1, 2023
David Beckmann, MD, MPH
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

CATR_QA1_Beckmann headshot_color.jpgDavid Beckmann, MD, MPH. 

Assistant professor of psychiatry and human behavior, Sidney Kimmel Medical College, Thomas Jefferson University. Philadelphia, PA.

Dr. Beckmann has no financial relationships with companies related to this material.

Clinical pearls on how to assess and treat substance-induced psychosis when you come across them in your clinic.


Read More
Clinical Update

Naltrexone: A Jack of All Trades?

April 1, 2023
Julio Cesar Nunes, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Julio Cesar Nunes, MD. Psychiatry resident, Yale University. New Haven, CT.

Noah Capurso, MD, MHS. Assistant professor of psychiatry, Yale University. New Haven, CT. Editor-in-chief of The Carlat Addiction Treatment Report.

Dr. Nunes and Dr. Capurso have no financial relationships with companies related to this material.

Naltrexone was once hailed as a treatment for all addictive disorders. While the hype has not entirely panned out, it still holds an important place in our armamentarium of addiction treatments. Here, we review the evidence for its use and provide prescribing recommendations.


Read More
Saks-BookCover_Whisler-Higgins.jpg
BOOK REVIEWS FOR PSYCHIATRISTS

Using Stories to Color the Stark Lines of Evidence-Based Medicine: Elyn R. Saks

February 9, 2023
Emily E. Whisler, DO and Edmund S. Higgins, MD.

The first in a series of interesting reading for psychiatrists


Read More
Substance_Use_Sites.jpeg

Supervised Drug Consumption Sites

November 14, 2022
Noah Capurso, MD, MHS and Christopher Clayton, MD, EdM

Once controversial, research clearly shows the benefit of these sites, and they have started opening in the United States.


Read More
apps.png
CARLAT WEBINAR

Navigating the Sea of Mental Health Apps

November 10, 2022
John Torous, MD, MBI

0.50 CME Credits. Dr. Torous covers the world of mental apps, including privacy, evidence, engagement challenges, ease of use, and clinical utility.


Read More

Learning Objectives, Trauma and Addiction, CATR Nov/Dec 2022

October 31, 2022
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

After reading these articles, you should be able to do the following.


Read More
RESEARCH UPDATE

Office-Based Opioid Treatment

October 31, 2022
Joshua Blum MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Joshua Blum, MD. Dr. Blum, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Some providers may be reluctant to treat patients with opioid use disorders with MOUD, especially in a busy primary care setting, fearing that these patients are “too complex.” In this observational study, investigators found that patients on MOUD are not all that different from everyone else.


Read More
therapy_shutterstock_2067560861.png
CLINICAL UPDATE

Trauma and Addiction

October 31, 2022
Will Rutland MD, JD, MPH
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Will Rutland, MD, JD, MPH. Assistant Professor and Psychiatry Clerkship Director, UAB Heersink, School of Medicine, Montgomery Regional Campus. Montgomery, AL.    

Dr. Rutland, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Here, we describe treatment approaches for patients with comorbid addiction and PTSD.


Read More
Previous 1 2 3 4 5 6 7 8 9 10 11 12 … 49 50 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • OUDFB1e_Cover_Binding.png

    Treating Opioid Use Disorder—A Fact Book (2024)

    All the tools you need to assess and treat patients struggling with opioid use disorder. 
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2675415191.jpg
    General Psychiatry

    How to Start a Psych Medication IV

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.